2024 - 2032 年临床参考实验室市场机会、成长动力、产业趋势分析与预测

Clinical Reference Laboratory Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月06日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球临床参考实验室市场估值为 456 亿美元，预计 2024 年至 2032 年复合年增长率为 6.2%。医疗保健不可或缺的一部分。这些设施为医疗保健提供者、医院和其他实验室提供服务，提供广泛的检测服务，从常规筛检到复杂的遗传和特定疾病的诊断。

慢性病和传染病的盛行率不断上升，极大地推动了市场的成长，从而刺激了对诊断测试的需求，特别是在管理慢性病方面。全球疾病负担不断上升凸显了临床参考实验室的重要作用，其中先进的血液检测、基因筛检和生物标记分析等服务对于早期检测、有效的疾病管理和长期健康监测至关重要。

按服务类型细分，市场包括医院实验室、独立实验室和诊所实验室。 2023 年，以医院为基础的细分市场处于领先地位，估值约 223 亿美元。这些医院实验室提供广泛的测试（从基础血液检查到复杂的分子诊断），使医疗保健提供者能够利用集中中心进行全面诊断，最终提高病患照护效率。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	456 亿美元
预测值	780 亿美元
复合年增长率	6.2%

从应用来看，市场分为临床试验和检验医学，到2023年，检验医学将占据超过67.6%的市场份额。医疗保健领域发挥基础作用。此类临床参考实验室进行深入的生化分析，以评估器官功能、检测代谢紊乱和监测慢性病，从而支持全面的患者健康管理。

光是美国临床参考实验室市场就在 2023 年达到 169 亿美元，其基础是糖尿病、癌症和自体免疫疾病等慢性病的高盛行率。这些实验室是美国医疗保健的核心，提供先进的生化和分子诊断，以提高患者护理品质和健康结果。由临床实验室改进修正案 (CLIA) 和 FDA 等实体领导的美国监管环境对实验室操作执行严格的标准，确保这个快速发展的行业的测试精度和患者安全。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性病和传染病的发生率上升
  - 生物参考实验室数量不断增加
  - 诊断测试数量不断增加
  - 老年人口不断增加
- 产业陷阱与挑战
  - 先进技术成本高
  - 严格的监理政策
成长潜力分析
监管环境
技术景观
- 核心技术
- 邻近技术
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按服务类型，2021 - 2032 年

主要趋势
以医院为基础
独立式
以临床为基础

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
临床试验
检验医学

第 7 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第 8 章：公司简介

Al Borg Medical Laboratories
Ampath Laboratories
ARUP Laboratories
Biolab
Eurofins Scientific
Laboratory Corporation of America Holdings
Laboratoires Reunis
Lifebrain Group
Lancet Laboratories
Mayo Clinic Laboratories
Medsol Diagnostics
Quest Diagnostics
Sonic Healthcare
Synlab Group
Unilabs

简介目录

Product Code: 12156

The Global Clinical Reference Laboratory Market was valued at USD 45.6 billion in 2023 and is projected to grow at a 6.2% CAGR from 2024 to 2032. Clinical reference laboratories, specialized in performing advanced diagnostic tests on samples like blood, urine, and tissue, are integral to modern healthcare. These facilities cater to healthcare providers, hospitals, and other labs, offering a wide range of testing services, from routine screenings to complex genetic and disease-specific diagnostics.

The market's growth is significantly driven by the increasing prevalence of chronic and infectious diseases, fueling the demand for diagnostic testing, particularly in managing chronic conditions. Rising global disease burdens underscore the essential role of clinical reference labs, where services such as advanced blood tests, genetic screenings, and biomarker analyses are crucial for early detection, effective disease management, and long-term health monitoring.

Segmented by service type, the market includes hospital-based, standalone, and clinic-based laboratories. In 2023, the hospital-based segment led with a valuation of approximately USD 22.3 billion. These hospital-based labs offer an extensive range of tests-spanning from basic blood work to sophisticated molecular diagnostics-allowing healthcare providers to leverage a centralized hub for comprehensive diagnostics, ultimately enhancing patient care efficiency.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$45.6 Billion
Forecast Value	$78 Billion
CAGR	6.2%

For applications, the market is divided into clinical trials and laboratory medicine, with laboratory medicine claiming over 67.6% of the market share in 2023. This segment plays a foundational role in healthcare by supplying essential diagnostic information that helps disease prevention, diagnosis, and treatment. Clinical reference labs within this category conduct in-depth biochemical analyses to assess organ function, detect metabolic disorders, and monitor chronic conditions, thereby supporting holistic patient health management.

The U.S. clinical reference laboratory market alone reached USD 16.9 billion in 2023, underpinned by a high prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders. These laboratories are central to U.S. healthcare, providing advanced biochemical and molecular diagnostics that elevate patient care quality and health outcomes. The U.S. regulatory environment, led by entities like the Clinical Laboratory Improvement Amendments (CLIA) and the FDA, enforces rigorous standards for laboratory operations, ensuring testing precision and patient safety in this rapidly growing sector.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of chronic and infectious diseases
  - 3.2.1.2 Growing number of bio reference laboratories
  - 3.2.1.3 Increasing number of diagnostic testing
  - 3.2.1.4 Rising geriatric population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of advanced technologies
  - 3.2.2.2 Presence of stringent regulatory policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Hospital-based
5.3 Standalone
5.4 Clinic-based

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Clinical trials
6.3 Laboratory medicine

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE